235 related articles for article (PubMed ID: 31836465)
21. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
22. Outcomes and predictors of clinical T1 renal mass (cT1) upstaged to pathological T3a (pT3a) after partial nephrectomy: A single-center experience.
Pathak N; Ganpule A; Patel D; Singh A; Shete N; Sabnis R; Desai M
Int J Urol; 2024 Mar; 31(3):252-257. PubMed ID: 38124339
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy.
Beksac AT; Paulucci DJ; Gul Z; Reddy BN; Kannappan M; Martini A; Sfakianos JP; Gin GE; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter J; Badani KK
Minerva Urol Nefrol; 2019 Aug; 71(4):395-405. PubMed ID: 30230296
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.
Takagi T; Yoshida K; Wada A; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Okumi M; Ishida H; Nagashima Y; Tanabe K
Int J Clin Oncol; 2020 May; 25(5):892-898. PubMed ID: 32048086
[TBL] [Abstract][Full Text] [Related]
25. Robotic surgery does not affect upstaging of T1 renal masses.
Davaro F; Roberts J; May A; McFerrin C; Siddiqui S; Hamilton Z
J Robot Surg; 2020 Jun; 14(3):447-454. PubMed ID: 31456083
[TBL] [Abstract][Full Text] [Related]
26. Perinephric and Sinus Fat Invasion in Stage pT3a Tumors Managed by Partial Nephrectomy.
Mouracade P; Dagenais J; Chavali JS; Kara O; Nelson RJ; Maurice MJ; Reese J; Rini BI; Kaouk JH
Clin Genitourin Cancer; 2018 Oct; 16(5):e1077-e1082. PubMed ID: 28818550
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of subclassifying stage pT3a renal tumors with fat invasion: a retrospective study of 99 patients.
Xu X; Zhu D
J Int Med Res; 2021 Aug; 49(8):3000605211033178. PubMed ID: 34382464
[TBL] [Abstract][Full Text] [Related]
28. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.
Nayak JG; Patel P; Saarela O; Liu Z; Kapoor A; Finelli A; Tanguay S; Rendon R; Moore R; Black PC; Lacombe L; Breau RH; Kawakami J; Drachenberg DE
Urology; 2016 Aug; 94():154-60. PubMed ID: 27041471
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy.
Lee H; Lee M; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BMC Cancer; 2018 Apr; 18(1):427. PubMed ID: 29661179
[TBL] [Abstract][Full Text] [Related]
30. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
31. Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset.
Veccia A; Antonelli A; Minervini A; Mottrie A; Dell'Oglio P; Ashrafi AN; Larcher A; Eun D; Bradshaw A; Amparore D; Brassetti A; Hampton LJ; Simeone C; Mari A; Carini M; De Naeyer G; Yang K; Capitanio U; Simone G; Porpiglia F; Derweesh I; Aron M; Autorino R
Urol Oncol; 2020 Apr; 38(4):286-292. PubMed ID: 31956077
[TBL] [Abstract][Full Text] [Related]
32. Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond.
Srivastava A; Patel HV; Kim S; Shinder B; Sterling J; Tabakin AL; Polotti CF; Saraiya B; Mayer T; Kim IY; Ghodoussipour S; Patel HD; Jang TL; Singer EA
Urol Oncol; 2021 May; 39(5):247-257. PubMed ID: 33223368
[TBL] [Abstract][Full Text] [Related]
33. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
[TBL] [Abstract][Full Text] [Related]
34. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
35. Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium.
Pruthi DK; Miller G; Ankerst DP; Neumair M; Capitanio U; Correa AF; Lane BR; Roussel E; McGregor TB; Derweesh IH; Cordeiro M; Pierorazio PM; Calvo C; Bi H; Noyes SL; Meagher M; Kutikov A; Uzzo RG; Van Poppel H; Larcher A; Montorsi F; Kattan MW; Kaushik D; Liss MA
J Urol; 2023 Nov; 210(5):750-762. PubMed ID: 37579345
[TBL] [Abstract][Full Text] [Related]
36. Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis.
Srivastava A; Patel HD; Joice GA; Semerjian A; Gorin MA; Johnson MH; Allaf ME; Pierorazio PM
Urol Oncol; 2018 Jan; 36(1):12.e7-12.e13. PubMed ID: 28970053
[TBL] [Abstract][Full Text] [Related]
37. Impact of pathological T3a upstaging on oncological outcomes of clinical T1 renal cell carcinoma: a meta-analysis.
Chen L; Deng W; Liu X; Wang G; Fu B
J Cancer; 2019; 10(20):4998-5006. PubMed ID: 31598172
[No Abstract] [Full Text] [Related]
38. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
40. Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma.
Lai GS; Li JR; Wang SS; Chen CS; Yang CK; Hung SC; Cheng CL; Ou YC; Chiu KY
In Vivo; 2020; 34(2):799-805. PubMed ID: 32111787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
